World's Best Scientists 2026 revealed!
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
H-index 22

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

1350-6129

Published by: Taylor & Francis

https://www.tandfonline.com/toc/iamy20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1209 72 99 20

Additional Metrics

Number of Best Scientists*: 114
Documents by Best Scientists*: 140
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 76
SCIMAGO SJR: 2.146
Impact Factor: 7.4

Overview

Top Research Topics at Amyloid?

Amyloid is mainly concerned with subjects like Amyloidosis, Pathology, Amyloid, Transthyretin and Internal medicine. Amyloid explores issues in Amyloidosis which can be linked to other research areas like Immunoglobulin light chain, AL amyloidosis, Molecular biology and AA amyloidosis. Amyloid explores themes in Pathology like Biopsy, Immunohistochemistry, Systemic amyloidosis and Disease and links them with other fields of study like In patient.

In the journal, Fibril, Biochemistry, Serum amyloid A and Antibody are investigated in conjunction with one another to address concerns in Amyloid research. Amyloid tackles topics on Fibril, which can potentially contribute to the wider field of Biophysics. Presentations on Biochemistry include those discussing Peptide and Peptide sequence.

In addition to Transthyretin research, Amyloid aims to explore topics under Liver transplantation, Polyneuropathy, Cardiomyopathy, Mutation (genetic algorithm) and Amyloid Neuropathy. Topics in Internal medicine explored in it were investigated in conjunction with research in Gastroenterology, Endocrinology, Surgery and Cardiology.

  • Amyloidosis (50.13%)
  • Pathology (38.30%)
  • Amyloid (33.51%)

What are the most cited papers published in the journal?

  • Tabulation of human transthyretin (TTR) variants, 2003. (416 citations)
  • Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis (369 citations)
  • Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. (338 citations)

Research areas of the most cited articles at Amyloid:

The most cited papers explore disciplines such as Amyloidosis, Amyloid, Pathology, Transthyretin and Internal medicine. While the primary focus in the journal publications is Amyloidosis, they also dissect topics surrounding Surgery and Adverse effect and Primary systemic amyloidosis as a whole. The Amyloid research presented in the journal papers also delves into studies in intersecting subjects like

  • Biochemistry that intertwine with fields like Biophysics and Amyloid fibril,
  • Serum amyloid A which intersects with area such as Allele..

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Disease

The previous edition focused in particular on these issues:

The discussions in Amyloid mainly cover the fields of Amyloidosis, Transthyretin, Pathology, Amyloid and AL amyloidosis. The studies on Amyloidosis discussed can also contribute to research in the domains of Disease progression, Genetics, Polyneuropathy, Response to treatment and Pediatrics. The research on Transthyretin tackled can also make contributions to studies in the areas of Human plasma, Amyloid polyneuropathy, Protein subunit and Potency.

The journal covers research in Pathology, particularly Amyloid deposition, Attr amyloidosis, Neuroendocrine tumour and Systemic amyloidosis and how they are related with concepts in Deposition (chemistry). The research on Amyloid featured in Amyloid combines topics in other fields like Fibril, Biophysics, Laser capture microdissection and Circular dichroism. The concepts on Internal medicine presented in it can also apply to other research fields, including Gastroenterology and Monoclonal protein.

The most cited articles from the last journal are:

  • Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis. (13 citations)
  • Next generation flow cytometry for MRD detection in patients with AL amyloidosis. (8 citations)
  • Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Amyloid (based on the number of publications) are:

  • Yukio Ando (100 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Shu-ichi Ikeda (83 papers) absent at the last edition,
  • Merrill D. Benson (66 papers) absent at the last edition,
  • Giampaolo Merlini (60 papers) published 2 papers at the last edition, 3 less than at the previous edition,
  • Per Westermark (59 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Amyloid (based on the number of publications) are:

  • Shinshu University (107 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Boston University (106 papers) absent at the last edition,
  • Kumamoto University (103 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Indiana University (73 papers) absent at the last edition,
  • Umeå University (68 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.55% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 38.78% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.08% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 28.57% of all publications and 28.57% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Potential Interdisciplinary Applications of Amyloid Research

A section on the potential interdisciplinary applications of Amyloid research would significantly enhance the depth of this article, as it would broaden the scope of analysis and provide valuable insights into the real-world implications of Amyloid studies. As Amyloid research advances, we're beginning to see its extensive implications across multiple disciplines. The topics covered in Amyloid research can contribute significantly to fields beyond biochemistry, biophysics, or internal medicine. For instance, elements such as 'Amyloid Neuropathy' or 'Liver Transplantation' can offer essential insights for lpn programs in New Mexico, which encompass courses on understanding and treating different types of neuropathies and complications post-transplantation.

Furthermore, studies on 'Disease Progression' or 'Response to Treatment' can benefit frontline healthcare providers dealing with diseases linked to Amyloids. Deep diving into the genetic aspects related to Amyloidosis also has potent ramifications in the domain of Genetics and Biogenetic engineering. Combined with interdisciplinary applications, Amyloid research holds essential clues for forging pioneering pathways in the medical world.

Therefore, it's clear that while Amyloid research is valuable on its own, its usefulness dramatically increases when observed through an interdisciplinary lens. As researchers and scholars continue to push the boundaries of understanding in this field, we may see even more surprising and beneficial interdisciplinary applications.

Top Publications

  • Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

    (2022)
    316 Citations
  • Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.

    Merrill D Benson;Joel N Buxbaum;David S Eisenberg;Giampaolo Merlini

    (2020)
    313 Citations
  • Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

    (2022)
    292 Citations
  • Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis

    (2022)
    148 Citations
  • Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group

    (2022)
    75 Citations
  • Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis.

    Giovanni Palladini;Stefan O. Schönland;Vaishali Sanchorawala;Shaji Kumar

    (2021)
    71 Citations
  • Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines.

    Vaishali Sanchorawala;Mario Boccadoro;Morie Gertz;Ute Hegenbart

    (2021)
    70 Citations
  • Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.

    Francesco Cappelli;Giacomo Tini;Domitilla Russo;Michele Emdin

    (2021)
    64 Citations
  • ATTRv amyloidosis Italian Registry: clinical and epidemiological data

    Massimo Russo;Laura Obici;Ilaria Bartolomei;Francesco Cappelli

    (2020)
    63 Citations
  • Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis

    Laura Obici;John L. Berk;Alejandra González-Duarte;Teresa Coelho

    (2020)
    59 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can offer diverse career opportunities. A 2 year nutrition degree online provides a fast track into healthcare roles focused on diet and wellness, complementing medical knowledge with practical nutrition expertise.

Healthcare leadership is another promising path. An affordable online mba in healthcare management equips professionals with business and administrative skills needed to manage healthcare organizations effectively.

If you’re a non-nurse looking to enter nursing, the best online bsn programs for non nurses offer accelerated routes for career changers to obtain a Bachelor of Science in Nursing, preparing them for direct patient care roles.

For advanced practice nurses, specializing as a psychiatric nurse practitioner can be fulfilling. The dnp psychiatric nurse practitioner salary data highlights competitive earnings, making this a viable and rewarding career path within the healthcare field.

Best Scientists Contributing to This Journal